UMB Bank’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $54.8K | Buy |
3,271
+492
| +18% | +$8.25K | ﹤0.01% | 1087 |
|
|
2025
Q1 | $42.7K | Buy |
2,779
+50
| +2% | +$768 | ﹤0.01% | 1118 |
|
|
2024
Q4 | $60.1K | Buy |
2,729
+290
| +12% | +$6.39K | ﹤0.01% | 840 |
|
|
2024
Q3 | $44K | Buy |
2,439
+2,067
| +556% | +$37.2K | ﹤0.01% | 914 |
|
|
2024
Q2 | $6.05K | Sell |
372
-3
| -0.8% | -$49 | ﹤0.01% | 1377 |
|
|
2024
Q1 | $5.29K | Hold |
375
| – | – | ﹤0.01% | 1375 |
|
|
2023
Q4 | $3.92K | Sell |
375
-205
| -35% | -$2.14K | ﹤0.01% | 1436 |
|
|
2023
Q3 | $5.92K | Buy |
580
+375
| +183% | +$3.83K | ﹤0.01% | 1391 |
|
|
2023
Q2 | $1.54K | Sell |
205
-505
| -71% | -$3.8K | ﹤0.01% | 1538 |
|
|
2023
Q1 | $6.28K | Buy |
710
+505
| +246% | +$4.47K | ﹤0.01% | 1379 |
|
|
2022
Q4 | $2K | Hold |
205
| – | – | ﹤0.01% | 1573 |
|
|
2022
Q3 | $2K | Hold |
205
| – | – | ﹤0.01% | 1625 |
|
|
2022
Q2 | $2K | Sell |
205
-1,103
| -84% | -$10.8K | ﹤0.01% | 1775 |
|
|
2022
Q1 | $12K | Sell |
1,308
-85
| -6% | -$780 | ﹤0.01% | 1443 |
|
|
2021
Q4 | $11K | Buy |
+1,393
| New | +$11K | ﹤0.01% | 1434 |
|